Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
ConclusionIn this specialist AF clinic, patients prescribed NOACs had a favourable adverse event profile with good efficacy for stroke prevention, with a low rate of cessation or switch to warfarin.
Source: International Journal of Clinical Practice - Category: Internal Medicine Authors: S. I. Lee, M. Sayers, G. Y. H. Lip, D. A. Lane Tags: Original Paper Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Electronic Medical Records (EMR) | Gastroenterology | History of Medicine | Internal Medicine | Ischemic Stroke | Pradaxa | Stroke | Vitamin K | Vitamins | Warfarin